Literature DB >> 21438134

Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C.

Karen W Gripp1, Elizabeth Hopkins, Katia Sol-Church, Deborah L Stabley, Marni E Axelrad, Daniel Doyle, William B Dobyns, Cindy Hudson, John Johnson, Romano Tenconi, Gail E Graham, Ana Berta Sousa, Raoul Heller, Maria Piccione, Giovanni Corsello, Gail E Herman, Marco Tartaglia, Angela E Lin.   

Abstract

Costello syndrome is characterized by severe failure-to-thrive, short stature, cardiac abnormalities (heart defects, tachyarrhythmia, and hypertrophic cardiomyopathy (HCM)), distinctive facial features, a predisposition to papillomata and malignant tumors, postnatal cerebellar overgrowth resulting in Chiari 1 malformation, and cognitive disabilities. De novo germline mutations in the proto-oncogene HRAS cause Costello syndrome. Most mutations affect the glycine residues in position 12 or 13, and more than 80% of patients share p.G12S. To test the hypothesis that subtle genotype-phenotype differences exist, we report the first cohort comparison between 12 Costello syndrome individuals with p.G13C and individuals with p.G12S. The individuals with p.G13C had many typical findings including polyhydramnios, failure-to-thrive, HCM, macrocephaly with posterior fossa crowding, and developmental delay. Subjectively, their facial features were less coarse. Statistically significant differences included the absence of multifocal atrial tachycardia (P-value = 0.033), ulnar deviation of the wrist (P < 0.001) and papillomata (P = 0.003), and fewer neurosurgical procedures (P = 0.024). Fewer individuals with p.G13C had short stature (height below -2 SD) without use of growth hormone (P < 0.001). The noteworthy absence of malignant tumors did not reach statistical significance. Novel ectodermal findings were noted in individuals with p.G13C, including loose anagen hair resulting in easily pluckable hair with a matted appearance, different from the tight curls typical for most Costello syndrome individuals. Unusually long eye lashes requiring trimming are a novel finding we termed dolichocilia. These distinctive ectodermal findings suggest a cell type specific effect of this particular mutation. Additional patients are needed to validate these findings.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438134      PMCID: PMC4166651          DOI: 10.1002/ajmg.a.33884

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  23 in total

Review 1.  High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities.

Authors:  Karen W Gripp; Elizabeth Hopkins; Daniel Doyle; William B Dobyns
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy.

Authors:  Anne L Estep; William E Tidyman; Michael A Teitell; Philip D Cotter; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2006-01-01       Impact factor: 2.802

3.  HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation.

Authors:  Karen W Gripp; Angela E Lin; Deborah L Stabley; Linda Nicholson; Charles I Scott; Daniel Doyle; Yoko Aoki; Yoichi Matsubara; Elaine H Zackai; Pablo Lapunzina; Antonio Gonzalez-Meneses; Jennifer Holbrook; Cynthia A Agresta; Iris L Gonzalez; Katia Sol-Church
Journal:  Am J Med Genet A       Date:  2006-01-01       Impact factor: 2.802

4.  Noonan-like syndrome with loose anagen hair: a new syndrome?

Authors:  Laura Mazzanti; Emanuele Cacciari; Alessandro Cicognani; Rosalba Bergamaschi; Emanuela Scarano; Antonino Forabosco
Journal:  Am J Med Genet A       Date:  2003-04-30       Impact factor: 2.802

5.  Analysis of the transforming potential of the human H-ras gene by random mutagenesis.

Authors:  O Fasano; T Aldrich; F Tamanoi; E Taparowsky; M Furth; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Practical guidelines for evaluation of loose anagen hair syndrome.

Authors:  Julie L Cantatore-Francis; Seth J Orlow
Journal:  Arch Dermatol       Date:  2009-10

7.  Elements of morphology: standard terminology for the periorbital region.

Authors:  Bryan D Hall; John M Graham; Suzanne B Cassidy; John M Opitz
Journal:  Am J Med Genet A       Date:  2009-01       Impact factor: 2.802

8.  Considerations for a multiaxis nomenclature system for medical genetics.

Authors:  N H Robin; L G Biesecker
Journal:  Genet Med       Date:  2001 Jul-Aug       Impact factor: 8.822

Review 9.  An unexpected new role of mutant Ras: perturbation of human embryonic development.

Authors:  Christian P Kratz; Charlotte M Niemeyer; Martin Zenker
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

10.  Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.

Authors:  Viviana Cordeddu; Elia Di Schiavi; Len A Pennacchio; Avi Ma'ayan; Anna Sarkozy; Valentina Fodale; Serena Cecchetti; Alessio Cardinale; Joel Martin; Wendy Schackwitz; Anna Lipzen; Giuseppe Zampino; Laura Mazzanti; Maria C Digilio; Simone Martinelli; Elisabetta Flex; Francesca Lepri; Deborah Bartholdi; Kerstin Kutsche; Giovanni B Ferrero; Cecilia Anichini; Angelo Selicorni; Cesare Rossi; Romano Tenconi; Martin Zenker; Daniela Merlo; Bruno Dallapiccola; Ravi Iyengar; Paolo Bazzicalupo; Bruce D Gelb; Marco Tartaglia
Journal:  Nat Genet       Date:  2009-08-16       Impact factor: 38.330

View more
  26 in total

1.  Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.

Authors:  Yline Capri; Elisabetta Flex; Oliver H F Krumbach; Giovanna Carpentieri; Serena Cecchetti; Christina Lißewski; Soheila Rezaei Adariani; Denny Schanze; Julia Brinkmann; Juliette Piard; Francesca Pantaleoni; Francesca R Lepri; Elaine Suk-Ying Goh; Karen Chong; Elliot Stieglitz; Julia Meyer; Alma Kuechler; Nuria C Bramswig; Stephanie Sacharow; Marion Strullu; Yoann Vial; Cédric Vignal; George Kensah; Goran Cuturilo; Neda S Kazemein Jasemi; Radovan Dvorsky; Kristin G Monaghan; Lisa M Vincent; Hélène Cavé; Alain Verloes; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

2.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

3.  Chiari I malformation in defined genetic syndromes in children: are there common pathways?

Authors:  Veronica Saletti; Ilaria Viganò; Giulia Melloni; Chiara Pantaleoni; Ignazio Gaspare Vetrano; Laura Grazia Valentini
Journal:  Childs Nerv Syst       Date:  2019-07-30       Impact factor: 1.475

4.  A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development.

Authors:  Karen W Gripp; Eugenia Bifeld; Deborah L Stabley; Elizabeth Hopkins; Stefanie Meien; Kathy Vinette; Katia Sol-Church; Georg Rosenberger
Journal:  Am J Med Genet A       Date:  2012-07-20       Impact factor: 2.802

5.  Opposing brain differences in 16p11.2 deletion and duplication carriers.

Authors:  Abid Y Qureshi; Sophia Mueller; Abraham Z Snyder; Pratik Mukherjee; Jeffrey I Berman; Timothy P L Roberts; Srikantan S Nagarajan; John E Spiro; Wendy K Chung; Elliott H Sherr; Randy L Buckner
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

6.  Macrocerebellum, epilepsy, intellectual disability, and gut malrotation in a child with a 16q24.1-q24.2 contiguous gene deletion.

Authors:  Andrea H Seeley; Mark A Durham; Mark A Micale; Jeffrey Wesolowski; Bradley R Foerster; Donna M Martin
Journal:  Am J Med Genet A       Date:  2014-04-09       Impact factor: 2.802

7.  Cardiomyopathies in Noonan syndrome and the other RASopathies.

Authors:  Bruce D Gelb; Amy E Roberts; Marco Tartaglia
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01

8.  An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.

Authors:  Karen W Gripp; Katia Sol-Church; Patroula Smpokou; Gail E Graham; David A Stevenson; Heather Hanson; David H Viskochil; Laura C Baker; Bridget Russo; Nick Gardner; Deborah L Stabley; Verena Kolbe; Georg Rosenberger
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

9.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

10.  Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis.

Authors:  Karen W Gripp; Dina J Zand; Laurie Demmer; Carol E Anderson; William B Dobyns; Elaine H Zackai; Elizabeth Denenberg; Kim Jenny; Deborah L Stabley; Katia Sol-Church
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.